Also from this source

You just read:

Conatus Pharmaceuticals Presents Results From a Phase 2 Clinical Trial of CTS-1027 in HCV Genotype 1 Null-Responders

News provided by

Conatus Pharmaceuticals Inc.

Mar 31, 2011, 03:00 ET